| Recent development in pleiotropic effects of statins on cardiovascular disease through regulation of transforming growth factor-beta superfamily. | |
| | |
MedLine Citation:
|
PMID: 21700485 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: 3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known as statins, are a drug class that reduce the level of cholesterol in the blood. As a result, statins are used to suppress the progression of cardiovascular disease. Evidence points to another component of statins involving the non-lipid effects of the drug class in preventing cardiovascular disease. One specific mediator of this action is the transforming growth factor β (TGF-β) superfamily. The TGF-β superfamily consists of proteins that include TGF-β and bone morphogenetic proteins (BMPs). These proteins regulate cellular pathways to mediate effects including immunomodulation, cell cycling, and angiogenesis. One pathway that mediates these effects is Ras. Moreover, within this pathway, different functions are possible depending on the activation of the specific receptor subtype. This review discusses the recent development of the non-lipid effects of statins in preventing cardiovascular disease progression by regulating Ras pathway of the TGF-β superfamily, especially RhoA/ROCK pathway. METHODS: A systematic PubMed database search of all English-language articles up to 2011 was conducted using the following terms: statin, TGF-β, Ras, ROCK, GGPP, inducible nitric oxide synthase, endothelial nitric oxide synthase, actin filament formation, PPARγ, MMP-2, and human trials. CONCLUSION: With better understanding of the pathway, various mediators were identified; some of these mediators are important biomarkers producing more specific and accurate assessment of the pleiotropic effects of statins. The review of human trials also highlights that more specific biomarkers are employed in recent studies, and the non-lipid effects on human subjects are more accurately documented. Confirmation of the accuracy of these biomarkers by further large-scale studies and further development of new biomarkers may prove an important path leading to better patient selection for treatment, and thus better cost-effectiveness may be achieved. |
| | |
Authors:
|
Sze Ma; Christopher Cheng-Hwa Ma |
Related Documents
:
|
9002945 - Ectopic expression of the erythropoietin receptor in a murine interleukin-6-dependent p... 22365165 - The role of inflammation in the cardio-renal syndrome: a focus on cytokines and inflamm... 19187095 - Interleukin-6 is required for the early induction of glial fibrillary acidic protein in... 3127525 - B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and t l... 10816135 - Telomere diminution as a cause of immune failure in old age: an unfashionable demurral. 15279625 - Trichomonas vaginalis-induced apoptosis in raw264.7 cells is regulated through bcl-xl, ... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-6-21 |
Journal Detail:
|
Title: Cytokine & growth factor reviews Volume: - ISSN: 1879-0305 ISO Abbreviation: - Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-6-24 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9612306 Medline TA: Cytokine Growth Factor Rev Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2011 Elsevier Ltd. All rights reserved. |
Affiliation:
|
King's College London School of Medicine, London SE1 7GL, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Differences in neutral foot positions when measured barefoot compared to in shoes with varying stiff...
Next Document: Expression level polymorphisms: heritable traits shaping natural variation.